Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
1.
J Prev Med Hyg ; 59(2): E145-E152, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30083622

ABSTRACT

INTRODUCTION: Clostridium difficile (CD) is the most common cause of health-care-associated infectious diarrhea with increasing incidence and severity in recent years. The main cause of hospital's acquired cross infections can be attributed to incorrect hand hygiene. We described the epidemiology of CD infection (CDI) in a teaching hospital in Southern Italy during a two years surveillance period and evaluated the health-care workers compliance to hand hygiene. METHODS: CDI Incidence rates were calculated as the number of patients with positive C. difficile toxin assay per 10,000 patient-days. Compliance with hand hygiene was the ratio of the number of performed actions to the number of opportunities observed. Approximately 400 Hand Hygiene (HH) opportunities/year /ward were observed. We finally checked out if any correlation could be found. RESULTS: From January 2015 to December 2016 a total number of 854 CD determinations were performed in patients with clinical symptoms of diarrhea. The search for toxins A and B was positive in 175 cases (21,2%), confirming the diagnosis of CDI. Compliance to hand hygiene was significantly inversely associated with the number of CDIs: the lower the compliance of health-care workers with hand hygiene the higher was the number of cases of CDIs (p = 0.003). CONCLUSIONS: According to our results proper handwashing of health-care workers appears to be a key intervention in interrupting CD cross infections regardless of age and type of department in which the patient is admitted.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/prevention & control , Cross Infection/prevention & control , Hand Hygiene , Cross Infection/epidemiology , Hand Disinfection , Hospitalization , Humans , Incidence , Infection Control/methods , Italy/epidemiology , Observation
2.
Clin Microbiol Infect ; 17(9): 1444-7, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21668577

ABSTRACT

We report the first outbreak caused by colistin-resistant Klebsiella pneumoniae producing KPC-3 carbapenamase in two Italian hospitals. This spread occurred in 1 month, and was caused by eight colistin-resistant and carbapenem-resistant Klebsiella pneumoniae isolates from eight patients. A further three isolates were obtained from the intestinal tract and pharyngeal colonization. All isolates were multidrug-resistant (MDR), including being resistant to colistin, but they were susceptible to gentamicin and tigecycline. PCR detection showed that all isolates harboured the bla(KPC-3) gene associated with bla(SHV-11) , bla(TEM-1) and bla(OXA-9) . All K. pneumoniae isolates, genotyped by pulsed-field gel electrophoresis and multilocus sequence typing, belonged to the same sequence type (ST)258 clone. From our data and a review of the international literature, K. pneumoniae ST258 seems to be the most widespread genetic background for KPC dissemination in Europe.


Subject(s)
Bacterial Proteins/metabolism , Colistin/pharmacology , Disease Outbreaks , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , beta-Lactamases/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/biosynthesis , Bacterial Typing Techniques/methods , Drug Resistance, Multiple, Bacterial , Hospitals , Humans , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests/methods , Sicily/epidemiology , beta-Lactamases/biosynthesis
3.
J Sports Med Phys Fitness ; 51(2): 268-74, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21681162

ABSTRACT

AIM: Even if youths are generally perceived to be healthy, adolescent years are associated with significant morbidity. Screening and counselling programmes seem to be cost-effective but adolescents prefer to rely on health care services for the treatment of diagnosed diseases or injuries rather than for preventive actions. Age oriented studies are needed for better understanding the health needs of adolescents in order to provide an adequate offer of preventive opportunities. METHODS: Eight hundred youths ranging from 13 to 18 years of age were recruited. Health status and risks were clustered into the following five categories: clinical assessment, substance use/abuse, nutritional habits, alcohol and tobacco consumption, physical status. Surprisingly, 33% of the youths were suggested to perform further clinical assessment and even more interestingly a significant number of them received a diagnosis of a symptomatic disorder for which he or she did not previously consider a medical visit to be necessary. RESULTS: As expected, alcohol consumption, tobacco smoking, drug use/abuse and sedentary habit represent the risky lifestyles commonly followed by adolescents. CONCLUSION: The present study confirms the importance of screening programs addressed to health issues and behavioural attitudes of adolescents even in light of the fact that they may underestimate even indicative symptoms.


Subject(s)
Health Behavior , Mass Screening , Adolescent , Female , Health Status , Humans , Italy , Life Style , Male , Pilot Projects , Risk Factors
4.
Eur J Clin Microbiol Infect Dis ; 29(10): 1277-85, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20602245

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasingly being reported among cystic fibrosis (CF) populations worldwide. In this paper, we sought to examine at the epidemiology, the molecular characterisation and the antibiotic resistance of MRSA isolates in our cohort of CF patients. All MRSA strains were collected prospectively at the University Hospital of Catania, Italy, during a two-year study between mid 2005 to mid 2007 and underwent molecular, pathotype and susceptibility characterisations. Our study demonstrates persisting infections with both hospital-associated (HA-) and community-associated (CA-)MRSA, including Panton-Valentine leukocidin (PVL)-positive strains, in our CF population with an overall prevalence of 7.8%. We demonstrated that, in these patients, persistence was sustained by either identical clones that underwent subtle changes in their toxin content or by different clones over time. The isolation of MRSA in our CF population aged 7-24 years was associated with an increased severity of the disease even if, due to the small sample of patients included and the paucity of data on the clinical outcome, these results cannot be conclusive. Furthermore, three strains were heteroresistant vancomycin-intermediate S. aureus (hVISA), questioning the use of glycopeptides in the treatment of MRSA infections in these patients.


Subject(s)
Cystic Fibrosis/complications , Methicillin Resistance , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Vancomycin Resistance , Adolescent , Bacterial Toxins/genetics , Bacterial Typing Techniques , Child , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , DNA Fingerprinting , DNA, Bacterial/genetics , Exotoxins/genetics , Genotype , Humans , Italy/epidemiology , Leukocidins/genetics , Microbial Sensitivity Tests , Prospective Studies , Staphylococcus aureus/isolation & purification , Virulence Factors/genetics , Young Adult
5.
Transplant Proc ; 42(4): 1043-5, 2010 May.
Article in English | MEDLINE | ID: mdl-20534219

ABSTRACT

INTRODUCTION: Contamination of preservation fluid is common, with a reported incidence of 2.2% to 28.0%, and may be a major cause of early morbidity after transplantation. Herein, we report our experience with routine examination of preservation fluid collected just before implantation, focusing on the rate of contamination and the clinical consequences to recipients. MATERIALS AND METHODS: We analyzed 62 samples of preservation fluid for microbial and fungal contamination. RESULTS: Twenty-four samples (38.7%) were contaminated with at least 1 organism. Bacterial contamination alone was observed in 18 samples; all patients received prophylactic treatment with intravenous piperacillin/tazobactam, 4.5 g/d for 10 days, without clinical sequelae. Six samples were contaminated with Candida species; all patients received prophylactic treatment with fluconazole, 100 mg/d for 3 months. One patient developed reversible acute renal failure due to ureteral obstruction by fungus balls at 30 days after transplantation. CONCLUSION: Contamination of preservation fluid occurs frequently after kidney transplantation. Bacterial contamination evolved without symptoms in most patients treated with prophylactic antibiotic therapy. Fungal contamination may be potentially life-threatening. However, graft nephrectomy is not mandatory if the involved Candida species is identified correctly and appropriate antifungal therapy is rapidly prescribed.


Subject(s)
Bacteria/isolation & purification , Candida/isolation & purification , Drug Contamination/statistics & numerical data , Kidney Transplantation/standards , Organ Preservation Solutions/standards , Antibodies, Monoclonal/therapeutic use , Antifungal Agents/therapeutic use , Antilymphocyte Serum/therapeutic use , Basiliximab , Female , Fluconazole/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/adverse effects , Male , Middle Aged , Organ Preservation Solutions/adverse effects , Recombinant Fusion Proteins/therapeutic use , Retrospective Studies
6.
Transplant Proc ; 40(6): 1873-6, 2008.
Article in English | MEDLINE | ID: mdl-18675076

ABSTRACT

INTRODUCTION: Successful renal transplantation strictly depends on good control of rejection and better prevention and treatment of infections, which remain serious threats. METHODS: This retrospective, observational study of 245 renal allograft recipients who underwent transplantation between January 2002 and December 2005 included a 21+/-10 months follow-up. RESULTS: A total of 110 (44.9%) patients developed an infective process during the posttransplantation period, namely, 232 infective processes. Eighty patients developed at least 1 episode of urinary tract infection (UTI) 11 patients (4%) had a wound infection, and 30 patients (12%) had pneumonia. We diagnosed 35 cases of bacteremia (35%), whereas cytomegalovirus (CMV) infection was demonstrated in 40 patients (16%). CONCLUSIONS: Immunosuppressive therapy, necessary to avoid acute and chronic rejection, exposes patients to a higher rate of infectious complications. The immunosuppressive protocols led to a relatively low incidence of infectious complications, mainly of little clinical significance. The highest incidence was evident by the sixth month after transplantation, when the immunosuppressive regimen exercised its most depressive effects on patient immune systems.


Subject(s)
Infections/epidemiology , Kidney Transplantation/adverse effects , Postoperative Complications/epidemiology , Adult , Aged , Bacteremia/epidemiology , Cytomegalovirus Infections/epidemiology , Drug Administration Schedule , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Middle Aged , Pneumonia/epidemiology , Postoperative Complications/microbiology , Postoperative Complications/virology , Retrospective Studies , Surgical Wound Infection/epidemiology , Transplantation, Homologous , Urinary Tract Infections/epidemiology
7.
Mult Scler ; 14(5): 698-700, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18566033

ABSTRACT

We evaluated the presence of IgA and IgG celiac disease-related antibodies in a sample of 217 patients with multiple sclerosis (MS) and in a sample of 200 controls not affected by neurological disorders. None of the 217 patients with MS presented IgG and IgA anti-gliadin, anti-endomysial antibodies, anti-tissue transglutaminase and anti-reticulin, whereas only one of the selected controls presented specific antibodies; this subject resulted to be effectively affected by celiac disease. Our data did not show an increased frequency of celiac disease among patients with MS.


Subject(s)
Celiac Disease/epidemiology , Multiple Sclerosis/epidemiology , Adult , Autoantibodies/blood , Benzylisoquinolines/immunology , Celiac Disease/immunology , Female , Gliadin/immunology , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Middle Aged , Multiple Sclerosis/immunology , Seroepidemiologic Studies , Transglutaminases/immunology
8.
J Clin Microbiol ; 43(10): 5136-42, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16207975

ABSTRACT

To analyze national prevalence, genomovar distribution, and epidemiology of the Burkholderia cepacia complex in Italy, 225 putative B. cepacia complex isolates were obtained from 225 cystic fibrosis (CF) patients attending 18 CF centers. The genomovar status of these isolates was determined by a polyphasic approach, which included whole-cell protein electrophoresis and recA restriction fragment length polymorphism (RFLP) analysis. Two approaches were used to genotype B. cepacia complex isolates: BOX-PCR fingerprinting and pulsed-field gel electrophoresis (PFGE) of genomic macrorestriction fragments. A total of 208 (92%) of 225 isolates belonged to the B. cepacia complex, with Burkholderia cenocepacia as the most prevalent species (61.1%). Clones delineated by PFGE were predominantly linked to a single center; in contrast, BOX-PCR clones were composed of isolates collected either from the same center or from different CF centers and comprised multiple PFGE clusters. Three BOX-PCR clones appeared of special interest. One clone was composed of 17 B. cenocepacia isolates belonging to recA RFLP type H. These isolates were collected from six centers and represented three PFGE clusters. The presence of insertion sequence IS 1363 in all isolates and the comparison with PHDC reference isolates identified this clone as PHDC, an epidemic clone prominent in North American CF patients. The second clone included 22 isolates from eight centers and belonged to recA RFLP type AT. The genomovar status of strains with the latter RFLP type is not known. Most of these isolates belonged to four different PFGE clusters. Finally, a third clone comprised nine B. pyrrocinia isolates belonging to recA RFLP type Se 13. They represented three PFGE clusters and were collected in three CF centers.


Subject(s)
Burkholderia Infections/transmission , Burkholderia cepacia complex/isolation & purification , Cystic Fibrosis/epidemiology , Cystic Fibrosis/microbiology , Disease Outbreaks , Bacterial Typing Techniques , Burkholderia Infections/epidemiology , Burkholderia Infections/microbiology , Burkholderia cepacia complex/classification , Burkholderia cepacia complex/genetics , Clone Cells , Electrophoresis, Gel, Pulsed-Field , Genotype , Humans , Italy/epidemiology , Polymerase Chain Reaction/methods , Prevalence , Sputum/microbiology
9.
J Clin Microbiol ; 39(8): 2891-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11474009

ABSTRACT

The prevalence, epidemiology, and genomovar status of Burkholderia cepacia complex strains recovered from Italian cystic fibrosis (CF) patients were investigated using genetic typing and species identification methods. Four CF treatment centers were examined: two in Sicily, one in central Italy, and one in northern Italy. B. cepacia complex bacteria were isolated from 59 out of 683 CF patients attending these centers (8.6%). For the two geographically related treatment centers in Sicily, there was a high incidence of infection caused by a single epidemic clone possessing the cblA gene and belonging to B. cepacia genomovar III, recA group III-A, closely related to the major North America-United Kingdom clone, ET12; instability of the cblA sequence was also demonstrated for clonal isolates. In summary, of all the strains of B. cepacia encountered in the Italian CF population, the genomovar III, recA group III-A strains were the most prevalent and transmissible. However, patient-to-patient spread was also observed with several other genomovars, including strains of novel taxonomic status within the B. cepacia complex. A combination of genetic identification and molecular typing analysis is recommended to fully define specific risks posed by the genomovar status of strains within the B. cepacia complex.


Subject(s)
Burkholderia Infections/complications , Burkholderia cepacia/classification , Burkholderia cepacia/genetics , Cystic Fibrosis/complications , Neoplasm Proteins , Proteoglycans , Bacterial Typing Techniques/methods , Burkholderia Infections/epidemiology , Burkholderia Infections/microbiology , Cystic Fibrosis/microbiology , DNA, Ribosomal/analysis , Electrophoresis, Gel, Pulsed-Field , Fimbriae Proteins , Genes, rRNA , Humans , Italy/epidemiology , Membrane Proteins/genetics , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prevalence , Proteins , Rec A Recombinases/genetics
10.
New Microbiol ; 23(3): 319-27, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10939047

ABSTRACT

This study addresses the epidemiologic relatedness of a collection of Pseudomonas aeruginosa isolates from cystic fibrosis patients attending the Pediatric Clinic, Catania, Sicily. Genome macrorestriction analysis after pulsed field gel electrophoresis (PFGE) was used to characterise all strains. Furthermore, a rapid typing procedure, developed in this study, based on polymerase chain reaction amplified ribosomal DNA spacer polymorphisms (PCR-ribotyping), straight from bacterial cultures, was used. On the basis of macrorestriction analysis after PFGE, persistence of infection was shown in all patients; two cross-transmission episodes were identified in the nosocomial as well as in the familiar environment. PCR-ribotyping proved to be useful for a DNA-based identification test, suitable for screening purposes. The rapid amplification protocol here tested is proposed to evaluate the discriminatory power of other specific target sequences in PCR-based typing assays, for epidemiologic purposes.


Subject(s)
Cystic Fibrosis/microbiology , Genome, Bacterial , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/genetics , Restriction Mapping , Ribotyping , Adolescent , Anti-Bacterial Agents/pharmacology , Child , Child, Preschool , Cystic Fibrosis/complications , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , DNA, Intergenic/genetics , DNA, Intergenic/metabolism , DNA, Ribosomal/genetics , DNA, Ribosomal/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Drug Resistance, Microbial , Female , Genotype , Humans , Infant , Male , Microbial Sensitivity Tests , Polymerase Chain Reaction , Polymorphism, Genetic , Pseudomonas Infections/complications , Pseudomonas Infections/microbiology , Pseudomonas Infections/transmission , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/drug effects , Sicily
11.
J Infect ; 39(1): 38-41, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10468127

ABSTRACT

OBJECTIVES: we investigated the cause of hypo-responsiveness to vaccines in splenectomized subjects. METHODS: we evaluated the immune responses to a Haemophilus influenzae type b vaccine and the sizes of lymphocyte subpopulations in 25 splenectomized and 45 non-splenectomized thalassaemic patients, in 12 individuals who had been splenectomized after trauma and in 20 controls. RESULTS: the immune response in the controls was significantly higher (P < 0.001) than in splenectomized patients after trauma and in both, the response was higher (P < 0.001) than in thalassaemic patients. In asplenic subjects after trauma, percentages of CD3 and CD4 cells were lower (P < 0.001) than in patients in the other groups; the controls had higher percentages of CD8 cells (P < 0.001) than patients in the other groups. The natural logarithm of the mean percentage of (CD19 showed a quadratic trend from thalassaemic patients through asplenic subjects to controls (P < 0.001). Levels of CD16+ natural killer (NK) cells were higher (P < 0.001) only in asplenic subjects after trauma. CONCLUSIONS: the significant decrease in the immune response of the splenectomized thalassaemic patients vs. non-splenectomized thalassaemic patients may, in part, be due to their basic immunological condition. Thus, the best strategy for protecting these subjects is to vaccinate them before the splenectomy.


Subject(s)
Haemophilus Vaccines/immunology , Haemophilus influenzae type b/immunology , Splenectomy , Adolescent , Adult , Child , Female , Haemophilus Vaccines/administration & dosage , Haemophilus Vaccines/adverse effects , Humans , Immune Tolerance , Lymphocyte Count , Lymphocyte Subsets/cytology , Lymphocyte Subsets/immunology , Male , Splenectomy/adverse effects
12.
Arch Dis Child ; 78(1): 54-7, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9534677

ABSTRACT

The immune response to intradermal or intramuscular hepatitis B vaccine in 18 children with insulin dependent diabetes mellitus (IDDM) compared with 24 healthy children was studied. Patients were divided into responders, hyporesponders, and non-responders according to their antihepatitis B serum concentrations after hepatitis B vaccination. We also studied HLA class II antigen distribution and did delayed type hypersensitivity (DTH) tests on children with IDDM and controls. No difference in the immune response (antihepatitis B surface antigen antibody titres) was found with intramuscular administration, whereas with intradermal administration a statistically lower immune response (p < 0.001) was observed in children with IDDM v controls. This hyporesponsiveness cannot be attributed to HLA class II antigen distribution because their frequency was the same in both groups of children with IDDM. It is suggested that the poor immune response to intradermal hepatitis B vaccine may be due to impaired macrophage activity resulting in failure of antigen presentation, which may be of importance in the immune dysfunction in children with IDDM. This hypothesis is suggested by a significantly lower score on a DTH test to a battery of antigens in the IDDM group when compared with controls. It is therefore suggested that when the hepatitis B vaccination is offered to children with IDDM it may be preferable to give it intramuscularly.


Subject(s)
Diabetes Mellitus, Type 1/immunology , Hepatitis B Vaccines/immunology , Immune Tolerance , Adolescent , Child , Child, Preschool , Cohort Studies , Female , HLA-D Antigens/analysis , Hepatitis B Antibodies/biosynthesis , Hepatitis B Vaccines/administration & dosage , Humans , Hypersensitivity, Delayed/immunology , Injections, Intradermal , Injections, Intramuscular , Male
13.
J Pediatr Gastroenterol Nutr ; 24(5): 559-62, 1997 May.
Article in English | MEDLINE | ID: mdl-9161952

ABSTRACT

BACKGROUND: We carried out a study of the antibody pattern in 50 celiac children [34 females (F) and 16 males (M); F/M, 2.1], ages 7 months-15 years, compared with that in 25 control subjects (13 females and 12 males) of the same age. METHODS: IgA and IgG antigliadin antibodies (AGA) were determined with an enzyme-linked immunosorbent assay technique. IgA anti-R1-reticulin antibodies (ARA) and IgA antiendomysium antibodies (EmA) were determined with the fluorescein isothiocyanate-conjugate-labeled anti-human immunoglobulin technique. To compare sensitivity and specificity, EmA were identified using monkey esophagus and human umbilical cord as substrates. RESULTS: While AGA (IgA and IgG) showed a high sensitivity but a low specificity, ARA showed a high specificity but a low sensitivity. Data on EmA showed a high sensitivity and specificity with both tissue sections, with monkey esophagus being more sensitive (96%) and umbilical cord more specific (100%). CONCLUSIONS: Our results confirm the importance of celiac disease-related antibodies in identifying celiac children. Moreover, the easy availability of human umbilical cord indicates that it would be proper to use this tissue as substrate, instead of monkey esophagus, for EmA search in the future.


Subject(s)
Celiac Disease/immunology , Gliadin/immunology , Immunoglobulin A/blood , Immunoglobulin G/blood , Myofibrils/immunology , Reticulin/immunology , Adolescent , Animals , Biopsy , Celiac Disease/blood , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay , Esophagus/immunology , Female , Fluorescent Antibody Technique, Indirect , Haplorhini , Humans , Immunoglobulin A/immunology , Immunoglobulin G/immunology , Infant , Male , Reference Values , Umbilical Cord/immunology , Umbilical Cord/pathology
14.
Pediatr Med Chir ; 19(1): 27-30, 1997.
Article in Italian | MEDLINE | ID: mdl-9280904

ABSTRACT

We prospectively determined serum concentrations of soluble intercellular adhesion molecule 1 (sICAM-1) in the first 2 weeks of life in 32 preterm newborns in an attempt to assess whether these concentrations are reliable markers of sepsis in newborns at risk of infection. Ten of the study group were normal and had been hospitalized only for low birth weight. The remaining 22 presented respiratory distress (RDS) and were at even higher risk of infection because they required assisted mechanical ventilation and central venous catheterisation for parenteral feeding and infusion therapy. Sepsis was diagnosed in 11/22 newborns with RDS: in 3 on day 3 and in 8 on day 7. Circulating sICAM-1 concentrations were significantly elevated in neonates with RDS (group II) and associated infection (group III) compared with normal newborns (group I). However, after day 3 of life sICAM-1 values were significantly higher in group III than in group II.


Subject(s)
Infant, Premature/blood , Intercellular Adhesion Molecule-1/blood , Respiratory Distress Syndrome, Newborn/diagnosis , Sepsis/diagnosis , Age Factors , Biomarkers , Humans , Infant, Newborn , Prospective Studies , Respiratory Distress Syndrome, Newborn/blood , Risk Factors , Sepsis/blood
15.
Bone Marrow Transplant ; 19(2): 157-60, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9116613

ABSTRACT

We evaluated the immune status with respect to HBV and the immune response to readministration of HBV vaccine in a series of 20 patients with homozygous beta-thalassemia, aged 6-23 years (mean age: 13.0 +/- 4.2) who had undergone allogeneic bone marrow transplantation (BMT). Thirteen of them (group A), had received three doses of plasma-derived HBV vaccine from 7 to 5 years before BMT and 4-5 weeks after the last dose of vaccine, they had had high serum levels of HBV antibodies (anti-HBs). The remaining seven patients (group B) had had clinical symptoms and laboratory evidence of HBV infection in childhood with markedly elevated serum of anti-HBs. Before revaccination, a significantly lower percentage of patients (P < 0.005) with seropositive levels of anti-HBs was observed in group A than in group B. After administration of the second dose of HBV vaccine the percentage of subjects with protective levels of anti-HBs rose to 100% in both groups of patients even if the geometric mean of titers of anti-HBs increased more significantly in group B patients than in group A. We conclude that the serum levels of anti-HBs afforded by HBV vaccine administered from 7 to 5 years previously are very low and probably non-protective in most beta-thalassemic patients after allogeneic BMT, and that at least two doses of HBV vaccine should be readministered from 18 to 24 months after BMT to achieve adequate and long-term protection from HBV.


Subject(s)
Bone Marrow Transplantation/immunology , Hepatitis B Vaccines/administration & dosage , Hepatitis B/immunology , Immunity , beta-Thalassemia , Adolescent , Adult , Bone Marrow Transplantation/adverse effects , Child , Hepatitis B/etiology , Hepatitis B/prevention & control , Humans , Transplantation, Homologous , beta-Thalassemia/immunology , beta-Thalassemia/therapy
16.
Pediatr Med Chir ; 18(6): 615-7, 1996.
Article in Italian | MEDLINE | ID: mdl-9173412

ABSTRACT

The authors report a case of a child three years old, with severe malnutrition as complication of Ascaris lumbricoides infection. Intestinal nematodes infect many of the world's children and constitute a formidable public health problem. The infected children may suffer nutritional deficits, serious illness and occasionally death. Although infestation is uncommon in our country, it should be considered in children with low social life.


Subject(s)
Ascariasis/complications , Ascaris lumbricoides , Intestinal Diseases, Parasitic/complications , Nutrition Disorders/etiology , Acute Disease , Animals , Ascariasis/diagnosis , Child, Preschool , Diagnosis, Differential , Humans , Intestinal Diseases, Parasitic/diagnosis , Male , Nutrition Disorders/diagnosis
17.
New Microbiol ; 19(4): 293-300, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8914129

ABSTRACT

The epidemiological features of 60 multiresistant K. pneumoniae strains isolated from 1991 to 1995 in a neonatal ward are described. Antibiotic. Susceptibility testing and plasmid profile analysis were used as subtyping procedures. Antibiotic susceptibility typing was not informative enough since discrimination among isolates was typically poor. Plasmid profile analysis demonstrated that 58 out of 60 strains harboured one or more plasmid DNA bands, of different molecular weights ranging between 1.8 and 150 Mda. Small plasmids were best visualized after the alkaline lysis procedure, while large plasmids by the Kado and Liu method. A combination of plasmid patterns obtained by the two extraction procedures was used to define the final plasmid profile for each strain. Thirteen different plasmid profiles were identified among the collection of K. pneumoniae isolates from newborn patients of the same intensive care unit. The investigation showed that the strains were not responsible for a single outbreak.


Subject(s)
Intensive Care Units, Neonatal , Klebsiella pneumoniae/classification , Cross Infection/microbiology , Drug Resistance, Microbial , Drug Resistance, Multiple , Humans , Infant, Newborn , Italy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Plasmids/genetics
18.
Pediatr Med Chir ; 17(6): 563-6, 1995.
Article in Italian | MEDLINE | ID: mdl-8668594

ABSTRACT

Plasma fibronectic (pFN) is a high molecular weight multifunction glycoprotein, which augments neutrophil and macrofage phagocytosis and acts as a nonspecific opsonin for the reticuloendothelial system. In this study we have determined pFN concentrations in fifty eight preterm infants to discriminate infected from non infected ones. Concentrations of pFN decreased from baselin in babies with early or late onset infections. The changes in pFN concentrations were not found before sepsis, but on day 1. By day 5 pFN concentrations have increased and have been no longer different from controls. We have calculated sensitivity (73.68%), specificity (74.36%), positive (58.35%) and negative (85.29%) predictive values of pFN and of other markers of infections (C-reactive protein--CRP-, Immature/Mature neutrophil ratio--I/M n. ratio-). Adding these tests to pFN, provided equal specificity and positive predictive value, but increased sensitivity (94.73%) and negative predictive value (96.43%). Thus, low concentrations of pFN may be a valuable but not early marker for neonatal infections. The combination of pFN, CRP and I/M n. ratio increase the precision of diagnostic testing.


Subject(s)
Bacterial Infections/blood , Candidiasis/blood , Fibronectins/blood , Infant, Premature, Diseases/blood , Age Factors , Gestational Age , Humans , Infant, Newborn , Klebsiella Infections/blood , Klebsiella pneumoniae , Nephelometry and Turbidimetry , Pseudomonas Infections/blood , Staphylococcal Infections/blood , Streptococcal Infections/blood , Streptococcus agalactiae
19.
Ann Ig ; 7(4): 251-5, 1995.
Article in English | MEDLINE | ID: mdl-8679165

ABSTRACT

Several reports have clearly demonstrated that intradermal way of administration of hepatitis B vaccine represent a valid alternative to the intramuscular route, producing an high percentage of seroconversion. The characteristics of the intradermal way, short time of immunization and lower cost, have induced us to conduct a clinical trial among 116 healthcare workers in a hospital setting, which represent an high risk group especially at their first admission to the hospital. 99 selected participants (average age 22 years, range 17-27) received, after screening for HBV markers, 5 mcg of vaccine intradermally on the volar surface of the forearm, according to the schedule 0, 15, 30 and 45 days. Serum samples were collected after one month from the last inoculation of vaccine. The percentage of seroconversions obtained was significantly high (93.9%) confirming that intradermal vaccination with hepatitis B vaccine may be appropriate in providing a rapid protection for certain population subgroups.


Subject(s)
Hepatitis B Vaccines/immunology , Hepatitis B/prevention & control , Nursing Staff, Hospital , Adolescent , Adult , Female , Hepatitis B/immunology , Hepatitis B Antibodies/blood , Hepatitis B Vaccines/administration & dosage , Hospitals, General , Humans , Hypersensitivity, Delayed/immunology , Injections, Intradermal , Italy , Male , Time Factors
20.
Pediatr Med Chir ; 17(2): 173-5, 1995.
Article in Italian | MEDLINE | ID: mdl-7610086

ABSTRACT

Systemic Candida A. infections are increasing in Neonatal Intensive Care Units. For many years, Amphotericin B, alone or in combination with 5-fluorocytosine, have been used. Recently a search for new and less toxic drugs has been started. In this study we report the case of hepatic candidosis in a preterm newborn. The patient has been treated with itraconazole, an oral antifungal agent with broad spectrum activity. Its tolerance has been good. No severe side effects were observed and biochemical parameters showed no consistent drug induced effects.


Subject(s)
Candidiasis/drug therapy , Infant, Premature, Diseases/microbiology , Itraconazole/administration & dosage , Liver Diseases/microbiology , Administration, Oral , Humans , Infant, Newborn , Infant, Premature, Diseases/drug therapy , Intensive Care Units, Neonatal , Italy , Liver Diseases/drug therapy , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...